06.03.2013 Views

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />

Tel: +31 26 378 21 00<br />

Fax: +31 26 364 05 67<br />

Home Page: www.novartis.nl<br />

De scrip tion: De vel oper, im porter, pro moter,<br />

sales/detailer. Sells/de tails for other com pa nies.<br />

Prod uct ranges in clude: phar ma ceu ti cal prod ucts<br />

(branded, pre scrip tion, non-pre scrip tion), hos pi -<br />

tal pharmaceuticals. Es tab lished 1997. 25 phar -<br />

ma ceu ti cal em ploy ees in 2005. Di vi sions include:<br />

Pharmaceutical; OTC.<br />

Rep re sen ta tives/De tail ers (Pharm, Num -<br />

ber): 11-20 (2005)<br />

Sub sid iary of: Novartis, Swit zer land (100%)<br />

Phar ma ceu ti cal Sales: US$ 190-200 mil lion<br />

Prod ucts (% of Sales by Lead ing 5): 65-70%<br />

Ther a peu tic Classes (% of Sales by Lead ing<br />

5): 70-75%<br />

Dose Forms (% of Sales by Lead ing 5):<br />

90-95%<br />

Prin ci pal Prod ucts:<br />

GLIVEC (antineoplastic other)<br />

DIOVAN (an gio ten sin-II an tag o nist plain)<br />

SANDOSTATINE (hor mone hy po tha lamic)<br />

CODIOVAN (an gio ten sin-II an tag o nist com bi na -<br />

tion)<br />

FORADIL (B2-stim u lant)<br />

Ther a peu tic Range:<br />

renin-an gio ten sin sys tem agents 29%<br />

antineoplastics 23%<br />

hor mones pi tu itary and hy po tha lamic 11%<br />

antiasthma and COPD prod ucts 7%<br />

CNS drugs other 5%<br />

Lead ing Dose Forms:<br />

coated tab lets 62%<br />

vi als 10%<br />

cap sules 7%<br />

pres sur ised aero sols 6%<br />

tab lets 6%<br />

NOVARTIS CON SUMER HEALTH<br />

Full Name: Novartis Con sumer Health B.V.<br />

Postal Ad dress: Postbus 2014, 4800 CA Breda<br />

Street Ad dress: Clau dius Prinsenlaan 142, 4818<br />

CP Breda<br />

Tel: +31 76 533 00 00<br />

Fax: +31 76 533 00 44<br />

Home Page: www.novartisconsumerhealth.nl<br />

De scrip tion: Dis trib u tor, sales/detailer. Prod uct<br />

ranges in clude: phar ma ceu ti cal prod ucts<br />

(branded, pre scrip tion, non-pre scrip tion). 13<br />

phar ma ceu ti cal employees in 2007.<br />

Rep re sen ta tives/De tail ers (Pharm, Num -<br />

ber): 3 (2007)<br />

Con tacts (Pharm): Chair man: Jalmar Wesslink;<br />

Com mer cial Op er a tions: Bas Vorste Veld; Mar ket<br />

Re search: Rieny Fokker; Gen eral Con tact: Rieny<br />

Fokker<br />

Sub sid iary of: Novartis, Swit zer land (100%)<br />

SANDOZ<br />

Postal Ad dress: Postbus 10332, 1301 AH<br />

Almere<br />

Street Ad dress: Veluwezoom 22, 1327 AH<br />

Almere<br />

Tel: +31 36 524 16 00<br />

Fax: +31 36 537 33 22<br />

Home Page: www.sandoz.nl<br />

De scrip tion: Dis trib u tor, pro moter,<br />

sales/detailer. Im ports, dis trib utes, pro motes,<br />

sells/de tails for other com pa nies. Prod uct ranges<br />

in clude: phar ma ceu ti cal prod ucts (branded,<br />

unbranded, pre scrip tion, non-pre scrip tion), hos -<br />

pi tal pharmaceuticals. Es tab lished 1963. 57 phar -<br />

ma ceu ti cal employees in 2005.<br />

Rep re sen ta tives/De tail ers (Pharm, Num -<br />

ber): 7 (2005)<br />

Con tacts (Pharm): Chair man: E. Gorka; Com -<br />

mer cial Op er a tions: H. Mol; Gen eral Con tact:<br />

Denise Heuberger<br />

Sub sid iary of: Novartis, Swit zer land (100%)<br />

Phar ma ceu ti cal Sales: US$ 230-240 mil lion<br />

Prod ucts (% of Sales by Lead ing 5): 30-35%<br />

Ther a peu tic Classes (% of Sales by Lead ing<br />

5): 45-50%<br />

Dose Forms (% of Sales by Lead ing 5):<br />

95-100%<br />

Prin ci pal Prod ucts:<br />

METOPROLOL-SDZ (beta-blocker agent plain)<br />

OMEPRAZOL-SDZ (antiulcerant)<br />

NIFEDIPINE-SDZ (cal cium an tag o nist plain)<br />

SIMVASTATINE-SDZ (cho les terol/triglyceride<br />

reg u lat ing prep a ra tion)<br />

PRAVASTATIN.NA-SDZ (cho les terol/triglyceride<br />

reg u lat ing prep a ra tion)<br />

Ther a peu tic Range:<br />

beta-block ing agents 24%<br />

ant ac ids/antiflatulents/antiulcerants 7%<br />

renin-an gio ten sin sys tem agents 7%<br />

psychoanaleptics 6%<br />

antibacterials sys temic 6%<br />

Lead ing Dose Forms:<br />

tab lets 61%<br />

coated tab lets 20%<br />

© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 190

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!